NYSE · Financial Statements
Abbott Laboratories (ABT) Financial Statements
$104.88
NYSE: ABT
Market Cap $181.48B
Overview Financials Dividend
Abbott Laboratories most recently reported annual revenue of $44.3B, net profit of $6.5B. Revenue grew at an average annual rate of 5.1% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $43.1B $43.7B $40.1B $42.0B $44.3B Operating Profit $9.2B $8.4B $6.4B $6.8B $8.0B Net Profit $7.1B $6.9B $5.7B $13.4B $6.5B EPS $3.94 $3.91 $3.27 $7.64 $3.72 Op Margin 21.4% 19.2% 16.0% 16.3% 18.2%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $75.2B $74.4B $73.2B $81.4B $86.7B Total Liabilities $39.2B $37.5B $34.4B $33.5B $33.9B Cash $9.8B $9.9B $6.9B $7.6B $8.5B Borrowings $19.3B $17.9B $15.9B $15.3B $15.1B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $10.5B $9.6B $7.3B $8.6B $9.6B Investing Cash Flow $-3.9B $-3.5B $-5.3B $-4.5B $-4.6B Financing Cash Flow $-2.0B $-3.6B $-1.1B $-1.0B $-975.0M Net Cash Flow $3.0B $83.0M $-3.0B $720.0M $906.0M Free Cash Flow $8.6B $7.8B $5.1B $6.4B $7.4B
Valuation & Return Ratios
Metric Value PEG Ratio -0.53 EV / EBITDA 20.40 FCF Yield 4.97% Quick Ratio 0.97 Interest Coverage 12.45 Return 1Y -15.77% Return 3Y 21.25% Return 5Y -4.10%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .